The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer.

Xiaoshun ShiXiaoying DongSylvia YoungAllen Menglin ChenXiguang LiuZhouxia ZhengKailing HuangDi LuSiyang FengGrant MorahanKaican Cai

Published in: Cancer medicine (2019)

Results of this network meta-analysis indicate that the PFS outcome of SCLC with Sun or Bev drugs is superior to that of Tha. The improved therapeutic impact of angiogenesis inhibitors on SCLC needs more evidence, such as long-term observation in clinical trials, to be validated.

Keyphrases

small cell lung cancer
systematic review
clinical trial
endothelial cells
vascular endothelial growth factor
meta analyses
wound healing
randomized controlled trial
phase ii
study protocol
network analysis